Rentosertib, an AI-discovered drug for idiopathic pulmonary fibrosis, was tested in a clinical trial and appeared to make patients’ biological age drop by about three to four years. The reported effect is framed as a surprising “bonus” of the treatment.
WHO:Rentosertib developers and clinical trial investigators
WHAT:Clinical trial results reported that rentosertib made patients appear biologically 3–4 years younger.
WHEN:Reported Sep 8, 2026 at 2:43 PM ET
WHERE:Location not specified
WHY:Cause not yet established.
Reporting from 2 identified publishers across this event arc.
